Health

UQ Researchers have developed a new nanotechnology to monitor drug resistance and diversity of individual cancer cells circulating in the body.

Professor Linda Lua, Director of the Protein Expression Facility housed at AIBN, is developing a new vaccine candidate for avian influenza.

Researchers have developed a new approach to delivering DNA into cells using spikey silica nanoparticles. These nanoparticles transport the genetic cargo across the cell wall while protecting it from degradation.

Trau group researchers are using nanotechnology for fabrication-free disease biomarker detection within a fluidic droplet. The “lab-in-a-drop” system can be extremely useful for the detection of disease nucleic acid biomarkers.

The Wolvetang laboratory at AIBN recently found that key areas of the brain affected in this disease can be recreated in the lab using patient-derived stem cells, and this has now been published in the journal Frontiers in Cellular Neuroscience.